Cadrenal Therapeutics
CVKD
#11070
Rank
C$6.67 M
Marketcap
C$2.16
Share price
0.00%
Change (1 day)
-86.86%
Change (1 year)

EPS for Cadrenal Therapeutics (CVKD)

EPS in 2026 (TTM): C-$7.43

According to Cadrenal Therapeutics's latest financial reports the company's current EPS (TTM) is C-$7.65. In 2025 the company made an earnings per share (EPS) of C-$9.48 an increase over its 2024 EPS that were of C-$12.46.

EPS history for Cadrenal Therapeutics from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$7.43-21.58%
2025C-$9.48-23.94%
2024C-$12.46-6.03%
2023C-$13.26